within Pharmacolibrary.Drugs.R_RespiratorySystem.R03B_OtherDrugsForObstructiveAirwayDiseasesInhalants.R03BB05_AclidiniumBromide;

model AclidiniumBromide
  extends Pharmacolibrary.Drugs.ATC.R.R03BB05;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>R03BB05</td></tr><td>route:</td><td>inhalation</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Aclidinium bromide is a long-acting muscarinic antagonist (LAMA) used as a bronchodilator for maintenance treatment of chronic obstructive pulmonary disease (COPD). It is administered by inhalation and approved for clinical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers (both male and female), single inhaled dose.</p><h4>References</h4><ol><li><p>Li, W, et al., &amp; Garcia-Gil, E (2023). The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants. <i>International journal of chronic obstructive pulmonary disease</i> 18 2725–2735. DOI:<a href=\"https://doi.org/10.2147/COPD.S434588\">10.2147/COPD.S434588</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38046981/\">https://pubmed.ncbi.nlm.nih.gov/38046981</a></p></li><li><p>Fuhr, R, et al., &amp; Aubets, J (2016). Pharmacokinetics of aclidinium bromide/formoterol fumarate fixed-dose combination compared with individual components: A phase 1, open-label, single-dose study. <i>Clinical pharmacology in drug development</i> 5(2) 109–117. DOI:<a href=\"https://doi.org/10.1002/cpdd.209\">10.1002/cpdd.209</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27138024/\">https://pubmed.ncbi.nlm.nih.gov/27138024</a></p></li><li><p>Armstrong, EM, et al., &amp; Kelley, KW (2014). The role of aclidinium bromide in the treatment of chronic obstructive pulmonary disease. <i>Hospital practice (1995)</i> 42(4) 99–110. DOI:<a href=\"https://doi.org/10.3810/hp.2014.10.1147\">10.3810/hp.2014.10.1147</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25502134/\">https://pubmed.ncbi.nlm.nih.gov/25502134</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end AclidiniumBromide;
